GLP-1s like Ozempic are among the most important drug breakthroughs ever
Published by The Economist
Oct 24, 2024
press
Merck, Pfizer Tout Promising Respective Data in RSV With High Rates of Prevention
Published by BioSpace
Oct 18, 2024
press
Mounjaro v Ozempic: Inside the race to reveal the best weight-loss jab
Published by iNews
Oct 18, 2024
press
The pandemic's 'far-reaching' impact on dentistry
Published by Becker's Dental Revi
Oct 15, 2024
press
VIRAL THREAT Risk of bird flu combining with seasonal flu to create mutant strain is 5 times higher – raising ‘pandemic’ fears
Published by The Sun
Oct 14, 2024
press
H5N1 could combine with seasonal flu to create a more dangerous virus strain
Published by The Telegraph
Oct 10, 2024
press
New INTREPID Alliance Antiviral Landscape Report Highlights Urgent Need to Bolster R&D Pipeline in Support of Global Pandemic Preparedness Efforts
Published by AP News
Oct 9, 2024
press
GSK touts 3-year data on RSV shot Arexvy after CDC's narrower usage recommendation
Published by Fierce Pharma
Oct 8, 2024
press
GSK ex-vaccines chief says group’s blockbuster flu jab is too expensive
Published by Financial Times
Sep 23, 2024
press
Novo’s Wegovy Price Tag for Stroke Prevention Is Higher in US
Published by Bloomberg
Sep 20, 2024
press
Novo’s Wegovy Puts a Higher Price on Heart Health in the US
Published by Bloomberg
Sep 20, 2024
press
GSK pursues co-administration of RSV and shingles vaccines
Published by EMJ
Sep 19, 2024
press
GSK touts co-administration data for RSV, shingles vaccines as narrowed CDC guidance threatens sales
Published by Fierce Pharma
Sep 18, 2024
press
Will Mpox be the new Covid?
Published by MoneyWeek
Sep 17, 2024
press
Uncertainty about billion-dollar potential behind Bavarian's latest cup rate
Published by Finans
Sep 11, 2024
press
First Ozempic-style weight-loss pill could be available within two years
Published by i newspaper
Sep 6, 2024
press
Cost-benefit of Influenza Vaccinations in Frontline Workers: A Dynamic Modelling Study
Published by MedRXiV
Aug 28, 2024
press
The IFPMA lists the main challenges to promote the development of new antibiotics (es)
Published by El Global
Aug 23, 2024
press
Countries should act faster to curb the spread of mpox
Published by The Economist
Aug 22, 2024
press
BioNTech/Pfizer Covid and flu combo vaccine falters in late-stage trial
Published by Financial Times
Aug 16, 2024
press
Weight loss pill - new boom for Novo Nordisk, Eli Lilly and Co.? (de)
Published by Handelsblatt
Aug 8, 2024
press
RSV vaccine makers remain optimistic about market despite CDC guidance
Published by BioPharma Dive
Aug 6, 2024
press
GSK strengthens its position as the RSV vaccine leader: It earns 112 million more than Pfizer in the first half of the year (es)
Published by El Español
Aug 4, 2024
press
GSK cuts vaccine sales outlook after RSV surprise, but CEO puts on bold front on peak potential
Published by Fierce Pharma
Jul 31, 2024
press
Moderna: State of play ahead of Q2 earnings, I'm (temporarily) pesimistic
Published by Seeking Alpha
Jul 30, 2024
press
With new CDC recommendations, RSV market's long-term value falls sharply in US: Airfinity
Published by Fierce Pharma
Jul 29, 2024
press
RSV vaccine market to decline 64% on CDC decision: report
Published by Seeking Alpha
Jul 27, 2024
press
The competitors with whom Novo and Lilly will compete for the obesity market (es)
Published by El Espanol
Jul 25, 2024
press
How France is preparing for dengue ahead of 'super-spreader' Paris Olympics
Published by India Today
Jul 24, 2024
press
Airfinity US RSV vaccine market estimate cut by 64% from $4.7bn to $1.7bn a year by 2030 following recommendations for single lifetime shot for elderly people
Published by Business Insider
Jul 24, 2024
press
GSK, Pfizer and Moderna face RSV vaccine sales slump
Published by Financial Times
Jul 24, 2024
press
How a single daily pill could soon be the future of losing weight
Published by The Telegraph
Jul 21, 2024
press
Anti-obesity medicines will move up to 150 billion by 2030 (es)
Published by La Nueva España
Jul 18, 2024
press
Are we sicker after the pandemic? Experts analyze outbreaks of infections
Published by MSN
Jul 18, 2024
press
Are we sicker after the pandemic? Experts analyze outbreaks of infections
Published by CNN Brazil
Jul 18, 2024
press
Intellectual property licensing of therapeutics during the COVID-19 crisis: lessons learnt for pandemic preparedness and response
Published by BioMed Central
Jul 2, 2024
press
Rovi will manufacture Moderna's respiratory syncytial virus vaccine (es)
Published by El Espanol
Jul 2, 2024
press
Ozempic manufacturer gets half the world on the slimming syringe (but not for the same price) (be)
Published by Nieuwsblad
Jun 30, 2024
press
Covid cases brought back from Mecca: the weekly health point (fr)
Published by Agence Ecofin
Jun 29, 2024
press
The new normal: Why do we feel more sick after Covid-19? (es)
Published by El Economista
Jun 28, 2024
press
The EMA gives the green light to the vaccine against the respiratory syncytial virus of the pharmaceutical company Moderna (es)
Published by El Espanol
Jun 28, 2024
press
These diseases have been transmitted more since Covid-19 (fr)